Next Generation Tools in Genetic Toxicology: Micronucleus Assay for Safety Assessment
Register your interest for more information on our upcoming webinar
Join the waiting list
To find out more and to offer feedback on what you’d like us to cover, complete the form and we’ll email you with more details in June.
Our speakers (Subject to change)
DR EWELINA HOFFMAN
LEAD INNOVATION SCIENTIST
My expertise is focused on in vitro biological modelling for respiratory diseases, alveolar cell-to-cell signaling and interactions, and in vitro toxicity testing. Before joining ImmuONE, I was a Postdoctoral Research Fellow at the University of Hertfordshire working on the development and validation of multi-parameter high-content assays to investigate alveolar macrophage responses to different stimuli.
At ImmuONE, I am a Principal Lead Scientist. I use my laboratory skills and expertise to develop and validate our current products portfolio and improve safety testing of new molecules by using high-throughput techniques. I also have a great passion for innovation that would help to comply with the 3Rs principles (replacement, reduction and refinement of animal research).
DR JATIN VERMA
SENIOR SCIENTIST
I completed my PhD in 2015 within the DNA Damage and Cancer Research Group at Swansea University. Since then, I have pursued a career in genetic toxicology and have worked as a postdoctoral researcher officer at Swansea University and as a study director in industry.
As a pre-clinical toxicologist, I have mastered platforms approved by regulators to assess an agent’s ability to induce gene mutation and chromosomal aberrations in mammalian cells. Besides this, I have successfully validated various automated in vitro screening platforms routinely used for screening potent DNA-damaging agents.
